Farmaginax (Suppositories) Instructions for Use
Marketing Authorization Holder
S.C. Rompharm Company S.R.L. (Romania)
ATC Code
G02BB (Intravaginal contraceptives)
Active Substance
Benzalkonium chloride (Rec.INN registered by WHO)
Dosage Form
| Farmaginax | Vaginal suppositories 18.9 mg: 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Vaginal suppositories white or light yellow in color, one end is pointed, the other has a funnel-shaped depression, homogeneous in longitudinal section.
| 1 supp. | |
| Benzalkonium chloride | 18.9 mg |
Excipients: semisynthetic glycerides.
5 pcs. – contour cell packs (1) – cardboard boxes.
5 pcs. – contour cell packs (2) – cardboard boxes.
Clinical-Pharmacological Group
Vaginal contraceptive with spermicidal action
Pharmacotherapeutic Group
Contraceptive agent for topical application
Pharmacological Action
Antiseptic with spermicidal action. It is a quaternary ammonium compound, belongs to cationic surfactants.
The spermicidal action is due to the ability of the active substance to destroy sperm membranes (first the flagella, then the heads), which makes it impossible for the egg to be fertilized by a damaged sperm.
The effect develops 5-10 minutes after insertion into the vagina.
Does not affect the normal vaginal microflora or the menstrual cycle.
In vitro, Benzalkonium chloride is active against Neisseria gonorrhoeae, Chlamydia spp., Trichomonas vaginalis, Herpes simplex type 2, Staphylococcus aureus. It has low activity against Gardnerella vaginalis, Candida albicans, Haemophilus ducreyi and Treponema pallidum. It is not active against Mycoplasma spp.
Pharmacokinetics
Benzalkonium chloride is not absorbed into the vaginal mucosa, it is removed by simple washing with water and with normal physiological secretions. When applied topically, it is practically not absorbed.
Indications
Local contraception.
ICD codes
| ICD-10 code | Indication |
| Z30.0 | General advice and consultation on contraception |
| ICD-11 code | Indication |
| QA21.1 | Encounter for general counseling and advice on contraception |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Insert one suppository deeply into the vagina 5-10 minutes before each sexual intercourse.
Ensure the suppository is placed correctly for optimal spermicidal effect.
The contraceptive action develops within the specified time frame after insertion.
For repeated intercourse, insert a new suppository each time.
Do not use for vaginal hygiene or as a lubricant.
Avoid genital hygiene with soap for 2 hours before and 2 hours after application, as soap inactivates the active substance.
Perform vaginal douching no sooner than 2 hours after intercourse.
Discontinue use in case of vaginitis, ulceration, or mucosal irritation until the condition resolves.
This method does not protect against sexually transmitted infections, including HIV.
Consult a physician for persistent vaginal symptoms or to discuss long-term contraceptive options.
Adverse Reactions
Possible allergic reactions, contact dermatitis, burning, itching in the vagina and/or partner’s penis, painful urination.
Contraindications
Hypersensitivity to benzalkonium chloride; vaginitis, ulceration and irritation of the vaginal and cervical mucosa.
Use in Pregnancy and Lactation
Not used during pregnancy. Does not have a negative effect on the course of pregnancy. It is not excreted in breast milk, can be used during breastfeeding.
Special Precautions
The effectiveness of contraception depends on the correct use of the drug containing Benzalkonium chloride.
In case of vaginal diseases, the use of benzalkonium chloride should be temporarily discontinued until the end of treatment with vaginal medications.
This method of contraception does not protect against sexually transmitted infections or those caused by HIV.
The use of soap for genital hygiene is prohibited 2 hours before and 2 hours after sexual intercourse, because soap destroys Benzalkonium chloride. Vaginal douching should be applied 2 hours after sexual intercourse.
Drug Interactions
Any drug used intravaginally can reduce the spermicidal effect of benzalkonium chloride.
Benzalkonium chloride is destroyed by soap.
Iodine solutions (including 0.1% iodonate solution) inactivate Benzalkonium chloride.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Cortexin, 10mg, 5ml, 10pcs 